Cerylid appoints expat high-flyer to advisory board
19 August, 2002 by Iain ScottMelbourne-based Cerylid Biosciences has appointed another internationally experienced scientist to its advisory board.
Eiffel pleased with micronised insulin study
19 August, 2002 by Melissa TrudingerMelbourne-based Eiffel Technologies has announced that a pre-clinical study using micronised insulin demonstrated increased efficacy over native insulin.
Revenues expected, failures weren't, says Amrad boss
16 August, 2002 by Melissa TrudingerAmrad released its end of financial year report on Friday, saying that revenues and expenses were in line with forecasts.
New appointments boost BioDiem team
16 August, 2002 by Iain ScottMelbourne drug discovery company BioDiem has appointed two new executives as it gears up for a public listing.
Autogen means business with new appointment
16 August, 2002 by Melissa TrudingerVictorian biotech Autogen has appointed a business development director whose role will be to spark new collaborations and capitalise on its IP.
Danes, Australians collaborate on 'handmade clones'
16 August, 2002 by Melissa TrudingerAustralian and Danish scientists have developed a breakthrough new technique to clone animals they term "handmade cloning."
Scientist airs fears as SA gears up for GM debate
14 August, 2002 by Melissa TrudingerA gene technology moratorium bill proposed by South Australian Democrat Ian Gilfillan could stifle world-leading research in the state, a leading researcher has warned.
Sirtex opens another treatment centre in the US
13 August, 2002 by Melissa TrudingerSydney biotech Sirtex Medical has opened its fifth US-based cancer treatment centre since the Food and Drug Administration (FDA) approved the company's SIR-Spheres cancer therapy in March.
Norwood patent position grows apace
12 August, 2002 by Melissa TrudingerNorwood Abbey has been issued two more US patents for its proprietary drug delivery platform.
New program to study sheep genomics launched
12 August, 2002 by Melissa TrudingerMeat and Livestock Australia has launched a $15 million sheep genomics project to identify genes and develop tests for immunity to internal parasites and early diagnosis of Ovine Johnes and other diseases, increased efficiency of muscle growth, and improved reproduction.
Big pharma's big commitment
12 August, 2002 by Tanya HollisIn two years' time, a Federal government program credited with encouraging the injection of vital funds into Australian research and development will draw to a close.
Biota in new Hep C partnership with Glaxo
12 August, 2002 by Melissa TrudingerBiota Holdings' US subsidiary Biota Inc has announced a collaboration with GlaxoSmithKline (GSK) to develop new drugs against Hepatitis C, using Biota Inc's proprietary Numax technology platform.
BresaGen wins FDA approval for catheter
08 August, 2002 by Tanya HollisIn a step towards improved application of cell therapies, South Australian company BresaGen has gained US Food and Drug Administration approval to market a catheter designed for the delivery of therapeutics to the brain.
Chemeq raises $8m
07 August, 2002 by Melissa TrudingerChemeq has raised $8 million in its latest placement to institutions and other sophisticated investors, bringing the total raised this year to $15.5 million.
Skin surface laser patent granted to Norwood
07 August, 2002 by Tanya HollisDrug delivery group Norwood Abbey has added another patent to its portfolio, the latest covering laser technology to alter the skin's surface.
